Am. J. Respir. Crit. Care Med., Volume 164, Number 3, August 2001, 486-493

Structural Alterations of Gene Complexes by Cystic Fibrosis Sputum

NIEK N. SANDERS, ELSA VAN ROMPAEY, STEFAAN C. DE SMEDT, and JOSEPH DEMEESTER

Faculty of Pharmacy, Laboratory of General Biochemistry and Physical Pharmacy, Ghent University, Ghent, Belgium

Gene complexes with optimal physicochemical characteristics for cystic fibrosis (CF) gene therapy in vitro may become inactive in vivo as a result of destruction upon interaction with CF mucus. Therefore, we examined in this study to what extent main sputum components (linear DNA, mucin, phosphatidylcholine, phosphatidylglycerol, and albumin) may disintegrate lipoplexes. We found that mixing linear DNA with lipoplexes, in concentration ratios as occurs in the mucus of patients with CF in clinical studies with lipoplexes, drastically altered the surface charge and size of our lipoplexes and resulted in the liberation of plasmid DNA from the lipoplexes. These concentration ratios occur in vivo when the DNA concentration in the sputum becomes > 2.7 mg/ml, a quite realistic concentration even in patients without acute exacerbations. Lipoplexes brought in contact with native CF sputa at clinically relevant concentration ratios dissociated when the DNA concentration in the sputa was > 2.7 mg/ml. However, when the linear DNA was degraded by recombinant human deoxyribonuclease I before lipoplexes were added, the linear DNA did not cause any dissociation of the lipoplexes. Addition of albumin and mucin to the lipoplexes in a clinically relevant concentration ratio changed the surface charge of the lipoplexes to negative, however, without release of plasmid DNA. Mucin, dipalmitoylglycerophosphocholine, and dipalmitoylglycerophosphoglycerol did not cause any change in lipoplex properties at clinically relevant concentration ratios.

Keywords: cystic fibrosis; gene delivery; gene complexes and stability

This article has been cited by other articles:

				M. Alipour, Z. E. Suntres, and A. Omri Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa J. Antimicrob. Chemother., August 1, 2009; 64(2): 317 - 325. [Abstract] [Full Text] [PDF]

				C. Norez, M. Pasetto, M. C. Dechecchi, E. Barison, C. Anselmi, A. Tamanini, F. Quiri, L. Cattel, P. Rizzotti, F. Dosio, et al. Chemical conjugation of {Delta}F508-CFTR corrector deoxyspergualin to transporter human serum albumin enhances its ability to rescue Cl- channel functions Am J Physiol Lung Cell Mol Physiol, August 1, 2008; 295(2): L336 - L347. [Abstract] [Full Text] [PDF]

				K. L. Palmer, L. M. Aye, and M. Whiteley Nutritional Cues Control Pseudomonas aeruginosa Multicellular Behavior in Cystic Fibrosis Sputum J. Bacteriol., November 15, 2007; 189(22): 8079 - 8087. [Abstract] [Full Text] [PDF]

				R. E. Vandenbroucke, B. Lucas, J. Demeester, S. C. De Smedt, and N. N. Sanders Nuclear accumulation of plasmid DNA can be enhanced by non-selective gating of the nuclear pore Nucleic Acids Res., June 21, 2007; (2007) gkm440v1. [Abstract] [Full Text] [PDF]

				N N Sanders, H Franckx, K De Boeck, J Haustraete, S C De Smedt, and J Demeester Role of magnesium in the failure of rhDNase therapy in patients with cystic fibrosis. Thorax, November 1, 2006; 61(11): 962 - 966. [Abstract] [Full Text] [PDF]

				L. Peeters, N. N. Sanders, K. Braeckmans, K. Boussery, J. Van de Voorde, S. C. De Smedt, and J. Demeester Vitreous: A Barrier to Nonviral Ocular Gene Therapy Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3553 - 3561. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 619 - 630. [Full Text] [PDF]